USD 18,000 to USD 30,000
4 to 6 weeks
70 to 90%
Bone marrow transplant (BMT) is a crucial treatment option for many serious blood-related diseases, including cancers like multiple myeloma and lymphoma. Among the various types of bone marrow transplants, autologous bone marrow transplants are one of the most commonly performed procedures worldwide. In this type, doctors use the patient's own healthy stem cells to restore damaged bone marrow after high-dose chemotherapy or radiation.
The cost of an autologous bone marrow transplant in India lies between USD 18,000 to USD 30,000. Due to its advanced medical infrastructure, highly experienced transplant specialists, and affordability, India has emerged as a leading destination for autologous BMT.
An autologous bone marrow transplant (auto-BMT) is a medical procedure in which a person's own stem cells are collected, stored, and later re-infused after giving high-dose chemotherapy. The purpose of this therapy is to kill cancerous cells or abnormal blood-forming cells using aggressive treatment while preserving the body's ability to regenerate healthy blood cells using the patient's own stem cells.
This differs from an allogeneic transplant, where the stem cells are obtained from a donor (such as a sibling or an unrelated, matched person).
In autologous BMT, because the stem cells come from your own body:
The therapy is beneficial when doctors want to use very high doses of chemotherapy to attack cancer without permanently damaging the bone marrow.
Autologous bone marrow transplants are primarily used in certain cancers of the blood and lymphatic system. They are not suitable for every disease, but for specific conditions, they provide remarkable improvements in survival and quality of life. Here are the primary diseases treated with autologous BMT:
Note: Autologous bone marrow transplant is not used for leukemia or genetic blood disorders like thalassemia or sickle cell disease — these require an allogeneic (donor) transplant.
Understanding how the treatment works can help ease anxiety and prepare you for what's ahead. Indian hospitals follow international standards and conduct each step of the transplant under sterile, closely monitored conditions. Let's break down the entire process of an autologous bone marrow transplant (BMT) in India.
Before starting treatment, doctors need to confirm that your organs are healthy enough to handle the transplant.
You'll undergo:
Based on these reports, the transplant team decides whether you are fit to proceed.
You will be given injections of growth factors (G-CSF) for a few days. These help your body push stem cells from your bone marrow into the bloodstream.
Once enough cells are available in the blood, doctors perform leukapheresis – a process where blood is drawn, stem cells are separated, and the rest of the blood is returned to your body. It's similar to a long blood donation and is usually painless.
Collected stem cells are frozen and safely stored in special liquid nitrogen tanks until the day of the transplant.
This is the main cancer-killing phase. You will receive very strong chemotherapy drugs to destroy cancer cells that may have survived earlier treatments. It also wipes out your existing bone marrow, making space for healthy new cells to grow.
Because of the high dose, you may experience:
Doctors and nurses will closely monitor you and provide supportive care to manage any adverse drug reactions.
Once chemotherapy is done, your frozen stem cells are thawed and infused back into your bloodstream through a central line. This process is similar to a blood transfusion and takes about 1–2 hours.
You will be monitored during the infusion to ensure no allergic reactions or complications occur.
After infusion, your stem cells will begin to settle (engraft) in your bone marrow and start making new blood cells. This takes 10 to 21 days on average.
During this time:
Once your white cell count rises above a certain level (ANC > 500), doctors begin planning your discharge.
After hospital discharge, you will stay nearby for 7 to 14 additional days, allowing doctors to continue monitoring you in outpatient clinics. Before going home, you will receive:
Most international patients are advised to stay in India for 4 to 6 weeks total from admission to return travel. Many Indian hospitals also offer online video consultations for long-term follow-up after you return to your home country.
When considering a life-saving treatment like a bone marrow transplant, understanding the exact costs helps you plan with clarity. In India, the average cost of an autologous bone marrow transplant ranges from INR 15,00,000 to INR 25,00,000 (approximately USD 18,000 to USD 30,000). This price includes most major medical services related to the transplant. The treatment is typically offered as a fixed package to international patients. Here's a detailed cost breakdown:
Total estimated cost: INR 15L–INR 25L (USD 18,000–USD 30,000), depending on the hospital and patient's needs.
One of the reasons international patients choose India for an autologous bone marrow transplant is the considerable cost advantage. Let's look at how much this treatment costs across different countries:
Country | Autologous BMT Cost (USD) |
India | USD 18,000 – USD 30,000 |
USA | USD 120,000 – USD 250,000 |
UK | USD 100,000 – USD 180,000 |
Germany | USD 110,000 – USD 200,000 |
Turkey | USD 40,000 – USD 60,000 |
Thailand | USD 45,000 – USD 70,000 |
Singapore | USD 80,000 – USD 150,000 |
Patients traveling to India can save over 70–80% on treatment costs. Even after adding flight tickets, hotel stays, and visa fees, India remains the most economical destination for autologous bone marrow transplants.
Indian hospitals offer comprehensive packages that cover most services from diagnosis to discharge. Here's what is typically included:
These packages are tailored to ensure that international patients receive transparent, upfront pricing with no hidden charges.
Despite the all-inclusive nature of BMT packages in India, there are a few items that may be charged separately depending on individual circumstances:
While the base price remains within the range mentioned, a few factors can influence the final cost of autologous BMT in India:
Recovery after an autologous BMT is a gradual process. Your body needs time to rebuild its immune system and blood cells. Most patients stay in the hospital for 3 to 4 weeks and then spend a few more days in India for outpatient follow-up.
Important: Avoid crowded places and unclean food for a few weeks after the procedure. Follow hygiene rules strictly.
Autologous BMT has a high success rate, especially in diseases like multiple myeloma and lymphoma, when done in early or relapsed stages. The survival rate depends on various factors, including age, disease type, treatment timing, and the doctor's level of expertise.
Disease | 1-Year Survival | Long-Term Remission |
Multiple Myeloma | 90–95% | 60–70% |
Hodgkin’s Lymphoma | 85–90% | 70–80% |
Non-Hodgkin’s Lymphoma | 75–85% | 60–75% |
Germ Cell Tumors | 70–80% | 50–65% |
Neuroblastoma (children) | 60–70% | 40–60% |
India is now one of the most preferred countries for affordable, high-quality bone marrow transplant treatment. The country combines medical excellence with budget-friendly pricing and compassionate care.
Indian hospitals offer more than just medical treatment. They provide comprehensive support to international patients, ensuring your visit is comfortable, stress-free, and well-managed.
An autologous bone marrow transplant can be a life-changing treatment. For international patients, India offers a perfect combination of medical excellence, affordability, and patient-friendly care. With costs up to 80% lower than the West and success rates that meet global benchmarks, patients from around the world are choosing India for their cancer and blood disorder treatments
Autologous bone marrow transplant in India has a high success rate. For diseases such as multiple myeloma and lymphoma, 1-year survival rates exceed 85%, and long-term remission is possible in approximately 60–70% of cases, depending on the patient's overall condition and the timing of treatment.
The typical stay in India is around 4 to 6 weeks. It includes pre-transplant evaluation, the transplant itself (21–28 days), and outpatient follow-up for 1–2 weeks before returning to your home country.
Yes, most hospitals offer fixed transplant packages for international patients. These packages cover medical consultations, tests, hospital stays, stem cell collection, chemotherapy, infusion, and post-transplant care. ICU stay and rare complications may be charged separately.
Autologous transplants are generally safe since your own cells are used. Still, risks include infections, low blood counts, fatigue, and rare complications like bleeding or delayed cell recovery. These are closely monitored and managed by the transplant team.
Yes. Many Indian centers perform BMT for patients up to 70 years of age, provided they are medically fit. A complete pre-transplant evaluation is done to assess risk and readiness.
Absolutely. Leading Indian hospitals, such as FMRI in Gurgaon, maintain sterile, HEPA-filtered transplant units with strict infection control measures. It is internationally accredited (JCI, NABH) and follows global BMT protocols.
To begin, you can send your medical reports to us. They will evaluate your case, share a treatment plan, and issue a visa invitation letter. Once your visa is ready, we will arrange everything from airport pickup to your treatment schedule.